Substitute for Raised S.B. No. 262
Session Year 2021
 


AN ACT REQUIRING MANUFACTURERS OF BRAND NAME PRESCRIPTION DRUGS TO PROVIDE SAMPLES OF SUCH DRUGS TO MANUFACTURERS OF GENERIC PRESCRIPTION DRUGS.

To promote competition in the prescription drug market by allowing developers of generic drugs and biosimilar products to obtain reference samples.

Introduced by:
General Law Committee

 New today  2-4 days old  5 days & older
  View or Add Notes to SB-262

Add Notes to SB-262

Go To My Bills


This bill is in My Bills.
Do you wish to go to My Bills?

Co-sponsors for Amendment LCO:

Bill History

 Date Action Taken
 5/27/2021House Calendar Number 554
 5/27/2021Favorable Report, Tabled for the Calendar, House
 5/26/2021Senate Passed
 5/18/2021Favorable Report, Tabled for the Calendar, Senate
 5/18/2021No New File by Committee on Appropriations
 5/18/2021(LCO)Reported Out of Legislative Commissioners' Office
 5/18/2021(LCO)Filed with Legislative Commissioners' Office
 5/17/2021(APP)Joint Favorable
 5/12/2021Referred by Senate to Committee on Appropriations
 5/4/2021Favorable Report, Tabled for the Calendar, Senate
 5/4/2021No New File by Committee on Judiciary
 5/4/2021(LCO)Reported Out of Legislative Commissioners' Office
 5/4/2021(LCO)Filed with Legislative Commissioners' Office
 5/3/2021(JUD)Joint Favorable
 4/28/2021Referred by Senate to Committee on Judiciary
 3/4/2021(LCO)File Number 12
 3/4/2021Senate Calendar Number 48
 3/4/2021Favorable Report, Tabled for the Calendar, Senate
 3/4/2021(LCO)Reported Out of Legislative Commissioners' Office
 2/26/2021(LCO)Referred to Office of Legislative Research and Office of Fiscal Analysis 03/03/21 5:00 PM
 2/17/2021(LCO)Filed with Legislative Commissioners' Office
 2/16/2021(GL)Joint Favorable
 1/25/2021Public Hearing 01/28
 1/22/2021Referred to Joint Committee on General Law

Co-sponsors of SB-262

NOTE: Please direct all inquiries regarding the status of bills to the Office of the House Clerk and/or Senate Clerks' Office.